1576 related articles for article (PubMed ID: 19512873)
21. Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex.
Staals LM; Driessen JJ; Van Egmond J; De Boer HD; Klimek M; Flockton EA; Snoeck MM
Acta Anaesthesiol Scand; 2011 Jul; 55(6):700-7. PubMed ID: 21574968
[TBL] [Abstract][Full Text] [Related]
22. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
23. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
[TBL] [Abstract][Full Text] [Related]
24. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
[TBL] [Abstract][Full Text] [Related]
25. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
[TBL] [Abstract][Full Text] [Related]
26. Maintenance and recovery characteristics after sevoflurane or propofol during ambulatory surgery in children with epidural blockade.
Guard BC; Sikich N; Lerman J; Levine M
Can J Anaesth; 1998 Nov; 45(11):1072-8. PubMed ID: 10021955
[TBL] [Abstract][Full Text] [Related]
27. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
[TBL] [Abstract][Full Text] [Related]
28. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.
Schaller SJ; Fink H; Ulm K; Blobner M
Anesthesiology; 2010 Nov; 113(5):1054-60. PubMed ID: 20885293
[TBL] [Abstract][Full Text] [Related]
29. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
30. Sugammadex: another milestone in clinical neuromuscular pharmacology.
Naguib M
Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
[TBL] [Abstract][Full Text] [Related]
31. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
32. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
33. Clinical implications of sugammadex.
Caldwell JE; Miller RD
Anaesthesia; 2009 Mar; 64 Suppl 1():66-72. PubMed ID: 19222433
[TBL] [Abstract][Full Text] [Related]
34. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex.
Eleveld DJ; Kuizenga K; Proost JH; Wierda JM
Anesth Analg; 2007 Mar; 104(3):582-4. PubMed ID: 17312212
[TBL] [Abstract][Full Text] [Related]
35. Potency and time course of mivacurium block during sevoflurane, isoflurane and intravenous anesthesia.
Lowry DW; Mirakhur RK; Carroll MT; McCarthy GJ; Hughes DA; O'Hare RA
Can J Anaesth; 1999 Jan; 46(1):29-33. PubMed ID: 10078399
[TBL] [Abstract][Full Text] [Related]
36. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
[TBL] [Abstract][Full Text] [Related]
37. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
[TBL] [Abstract][Full Text] [Related]
38. Sugammadex in clinical practice.
Mirakhur RK
Anaesthesia; 2009 Mar; 64 Suppl 1():45-54. PubMed ID: 19222431
[TBL] [Abstract][Full Text] [Related]
39. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
40. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
